Schedule 13G ownership disclosure

ASCENDIS PHARMA A/S

ADR · CUSIP: 04351P101

Event date: 2025-09-30

Filing-level shares
2,667,563
Percent of class
4.8%
  • T. Rowe Price Investment Management, Inc.

    Shares: 2,667,563 · Class: 4.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-25-000536
Form type
SCHEDULE 13G/A
Filer
Ascendis Pharma A/S
CIK
CIK 1612042
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub